StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$981.33+3.75 (+0.38%)

Close on Nov 12, 2026Market cap –P/E 50.1Yield –

argenx statistics

56 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
1.31%
10.9%
Float
62M
49M
Shares Held by Insiders
0.00%
12.1%
Shares Held by Institutions
45.7%
56.4%

Short sellingIndustry

Short Interest
1M
–
Short Interest Change
4.34%
-0.76%
Days to Cover
3.42
5.13

Stock price statisticsIndustry

52-Week High
$1072.75
–
52-Week Low
$661.85
–
20-Day Moving Average
$900.52
–
50-Day Moving Average
$925.75
–
200-Day Moving Average
$859.72
–
Average True Range (14)
$28.98
–
Price Change (1 Week)
9.67%
1.51%
Price Change (1 Month)
19.9%
-2.37%
Price Change (3 Months)
15.3%
-21.1%
Price Change (6 Months)
19.4%
-22.8%
Price Change (YTD)
16.7%
-22.6%
Price Change (1 Year)
10.3%
-21.0%
Price Change (3 Years)
100.2%
-24.8%
Price Change (5 Years)
216.9%
-76.9%
Average Volume (10 Days)
419,328
–
Average Volume (20 Days)
420,198
–
Average Volume (90 Days)
344,470
–
Relative Volume
1.31
0.80
Relative Strength Index (14)
64.2
44.7
Volatility (1 Year)
37.7%
80.2%
Beta (5 Years)
0.44
1.07

Returns on capitalIndustry

Return on Assets (ROA)
15.0%
-40.7%
Return on Capital Employed (ROCE)
12.5%
-38.1%

Financial positionIndustry

Current Ratio
5.12
3.31
Quick Ratio
3.50
2.41
Interest Coverage
258.16
-6.35

GrowthIndustry

Net Income Growth (YoY)
55.1%
-14.4%
EPS Growth (YoY)
53.1%
-11.7%

EfficiencyIndustry

Inventory Turnover
1.27
2.73
Profits Per Employee
$693.52K
-$683.67K
Employee Count
1,863
75

Income statement (TTM)Industry

Operating Income
$1.05B
-$20.99M
Pretax Income
$1.28B
-$13.23M
Net Income
$1.29B
-$21.61M
EBITDA
$1.05B
-$16.85M
EPS (Diluted)
$19.57
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$3.58B
$16.98M
Net Cash Per Share
$57.92
$0.72
Working Capital
$6.49B
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
$685.19M
-$12.27M
Capital Expenditures
-$6.17M
-$944.00K
Free Cash Flow
$679.03M
-$18.20M
FCF Per Share
$10.97
-$0.42

Taxes and interestIndustry

Interest Expense
$4.08M
$2.97M
Income Tax
-$13.43M
$74.00K
Effective Tax Rate
-1.05%
20.9%

Scores and fair valueIndustry

Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodARGXS&P 500DifferenceARGX per yearS&P 500 per year
1 month+20.8%-2.7%+23.5 pts
3 months+12.0%-1.7%+13.8 pts
Year to date+16.7%+11.9%+4.8 pts
1 year+10.3%+12.0%−1.7 pts
3 years+100.6%+78.2%+22.5 pts+26.1%+21.2%
5 years+216.9%+73.2%+143.7 pts+25.9%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M ARGX shares were sold short on Oct 30, 2026, up 4.3% from the previous report. At recent volumes it would take 3.4 days to buy them back. Over the last 20 sessions, 57.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,412,594+4.3%413,0483.4
Oct 15, 20261,353,843+0.1%542,7722.5
Sep 30, 20261,352,184+3.0%273,4674.9
Sep 15, 20261,313,174+4.3%208,0446.3
Aug 31, 20261,259,349+4.8%319,5713.9
Aug 14, 20261,202,082-9.9%276,4594.3
Jul 31, 20261,334,571-13.3%283,0774.7
Jul 15, 20261,539,375+6.1%302,8695.1
Jun 30, 20261,450,472-1.1%420,9713.5
Jun 15, 20261,466,999-18.8%375,5383.9
May 29, 20261,807,173-16.0%262,3786.9
May 15, 20262,150,508+3.5%345,9456.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?